Mettler-Toledo International Inc. (MTD): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Mettler-Toledo International ( MTD) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.1%. By the end of trading, Mettler-Toledo International rose $2.22 (1.4%) to $164.98 on average volume. Throughout the day, 204,363 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 246,400 shares. The stock ranged in a price between $162.99-$166.62 after having opened the day at $163.65 as compared to the previous trading day's close of $162.76. Other companies within the Health Services industry that increased today were: Response Genetics ( RGDX), up 14.3%, Tengion ( TNGN), up 13%, Kips Bay Medical ( KIPS), up 7.2%, and Invacare Corporation ( IVC), up 6.5%.

Mettler-Toledo International Inc. engages in the research, development, manufacture, and marketing of precision instruments and software primarily in Europe, North and South America, and Asia. Mettler-Toledo International has a market cap of $5.23 billion and is part of the health care sector. The company has a P/E ratio of 19.2, below the average health services industry P/E ratio of 19.7 and above the S&P 500 P/E ratio of 17.7. Shares are up 10.9% year to date as of the close of trading on Monday. Currently there are four analysts that rate Mettler-Toledo International a buy, one analyst rates it a sell, and five rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, notable return on equity and increase in stock price during the past year. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the negative front, ImmunoCellular Therapeutics ( IMUC), down 16.5%, Graymark Healthcare ( GRMH), down 7.6%, AtriCure ( ATRC), down 5.9%, and Unilife Corporation ( UNIS), down 5.6%, were all laggards within the health services industry with DaVita ( DVA) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

Health Care and Pharma Feeling the Wrath of Trump: Cramer's 'Mad Money' Recap (Wednesday 1/11/17)

Berkshire Hathaway, SAP, Dominion Resources: 'Mad Money' Lightning Round

These 5 Health Care Stocks Are Breaking Out This Christmas

Analysts' Actions -- AK Steel, Mettler-Toledo, Pure Storage, Phillips 66 and More